Ireland· IE-PA-PA22808/001/001
Idrolax 10g, powder for oral solution in a sachet
A macrogol product containing macrogol 4000, registered in Ireland by Mayoly Pharma France. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Macrogol is registered in 12 of 19 countries.
Countries holding a registration under ATC A06AD15 (macrogol), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Macrogol · ATC A06AD15
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
Price per daily dose
What a daily dose of macrogol costs, country by country.
Normalised to the WHO defined daily dose (10 g), the median price runs from $0.083 in Finland to $0.66 in Switzerland — a ×7.9 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Macrogol · price per daily dose (10 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.66
- FI Finland$0.083
The record
At a glance
HPRA (Ireland)- Active substance
- Macrogol 4000
- Manufacturer
- Mayoly Pharma France
- Country
- Ireland (IE)
- ATC code
- A06AD15
- ATC class
- Macrogol
- Defined daily dose
- 10 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA22808/001/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
449 interactions on record for macrogol.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Macrogol · interactions on record
449 records
- 37 severe
- 411 moderate
- 1 minor
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- ProcainamideC01BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Macrogol in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceFORLAX 10 g, poudre pour solution buvable en sachetMAYOLY PHARMA FRANCE
- NetherlandsForlax 10 g, poeder voor drank in sachetEU-Pharma B.V.
- PolandForlax 10 gMAYOLY PHARMA FRANCE
- FinlandCasenlaxCasen Recordati, S.L.
- SwedenCasenlax 10 g Pulver till oral lösning i dospåseCasen Recordati, S.L.
- BelgiumDulcosoft 10 gSanofi Belgium
- CzechiaFORLAXMayoly Pharma France, Rueil-Malmaison
- GermanyForlaxMayoly Pharma France
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Forlax, Macrogol 4000 Strides
- Belgium · Forlax, Forlax Junior
- Bulgaria · Касенлакс
- Cyprus · Macrogol 4000 Casen Recordati
- Czechia · Forlax
- Germany · Forlax, Laxatan
- Denmark · Casenlax, Macrogol 4000 Strides
- Estonia · Forlax, Proctolax
- Spain · Casenlax, Femlax
- Finland · Casenlax, Makrogoli Orion
- France · Forlax, Macrogol 4000 Arrow
- United Kingdom (Northern Ireland) · Dulcobalance, Peglax
- Greece · Cleenlax, Cleenlax Forte
- Italy · Casenjunior, Casenlax
- Lithuania · Forlax, Macrogol 4000 Casen Recordati
- Luxembourg · Forlax, Forlax Junior
- Latvia · Forlax, Proctolax
- Netherlands · Forlax, Forlax Junior
- Norway · Casenlax, Golax
- Poland · Forlax, Macrogol Aurovitas
- Portugal · Casenlax, Forlax
- Romania · Forlax, Proctolax
- Sweden · Casenlax, Forlax
- Slovakia · Forlax, Laxatan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9bb983e6-b976-402c-a87a-54a3634c25d0 GET /v1/drugs/9bb983e6-b976-402c-a87a-54a3634c25d0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for oral solution in sachet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"A06AD",
"A06AD15"
],
"strength": null,
"pa_number": "PA22808/001/001",
"substances": [
"Macrogol 4000"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "22/02/2002",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about macrogol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.